AP-1 activation, as determined by increased AP-1 DNA binding activity, is increased in both epithelial colonic and breast cancer cell lines following treatment with 10 and 30μm of 15dPGJ2 respectively (59, 60). This evidence concerns the gene FOS and breast carcinoma.